News | pharmachal

Pharmachal Signs Agreement with Rambam, Israel to Develop 'Ultimate 3-in-1 wound healing technology

Pharmachal Health Group and tier-1 Israeli trauma hospital Rambam Healthcare Campus have signed an agreement to develop a new product for...

Post Covid-19 Recovery with Triazavirin

Andrew Mendelawitz chatted with South African pharmacist Ian Lee about his experience catching Covid-19 and using broad-spectrum...

Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of

Introduction The urgency of the COVID-19 problem (CoronaVirus Disease 2019) is currently beyond doubt. In Russia alone, more than 4.5...

MEDIA RELEASE: PHARMACHAL BRINGS “GAMECHANGER”COVID-19 PILL USED BY OVER ONE MILLION TO AUSTRALIA.

Melbourne-based pharmaceutical company Pharmachal Health Group is hailing COVID-19 drug TRIAZAVIRIN™ – otherwise known as TZV – as a...

Interview with Ricard Securities

Pharmachal sat down with Michael van Cuylenburg, Director of the Ricard Group to talk about the company, its technology and its pathway...

PHARMACHAL LICENSES NOVEL ANTI-VIRAL CAPSULE IN FIGHT AGAINST COVID-19

Melbourne pharmaceutical company Pharmachal Health Group has secured regional distribution for the novel, broad-spectrum antiviral...

Corporate Presentation, July 2021

Pharmachal is pleased to present a new corporate presentation to kick of the financial year. Click below to download the presentation.

Pharmachal to List on Sydney Stock Exchange

Pharmachal Health Group has elected to list on the SSX as a stepping-stone towards listing on a major international exchange. Charles...

March 2021 Newsletter

MELBOURNE, TUESDAY 30 MARCH, 2021: Pharmachal Health Group (“PHG” or “Company”) is pleased to announce the achievement of a series of...

January 2021 Newsletter

Pharmachal Health Group is a Melbourne-based pharmaceutical company with a certified globally-patented mini-emulsion drug-in-oil delivery...

Pharmachal’s Oromed-Can Sublingual Cannabis Spray, a Breakthrough for the Industry

Pharmachal Health Group has developed a new means of administering medical cannabis to patients. Pharmachal’s Oromed-Can uses the...

Guatemalan Burns Treatment Feedback

Pharmachal Health Group’s NOPAYNE mini-emulsion lidocaine spray is currently being used in two hospitals in Guatemala, following the...

Guatemalan Volcano Burns Victims Treated with NOPAYNE

8 August, 2018 When the Volcan de Fuego (Fire Volcano) in Guatemala erupted in June, over 100 people died, another two hundred went...